220 related articles for article (PubMed ID: 32297007)
1. Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement.
Snyder JM; Pawloski JA; Poisson LM
Curr Oncol Rep; 2020 Apr; 22(5):45. PubMed ID: 32297007
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases.
Vaghela S; Tanni KA; Banerjee G; Sikirica V
Orphanet J Rare Dis; 2024 Mar; 19(1):117. PubMed ID: 38475874
[TBL] [Abstract][Full Text] [Related]
3. Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned.
Ro SK; Zhang W; Jiang Q; Li XN; Liu R; Lu CC; Marchenko O; Sun L; Zhao J
Ther Innov Regul Sci; 2023 Jul; 57(4):899-910. PubMed ID: 37179264
[TBL] [Abstract][Full Text] [Related]
4. Real-world Data for Clinical Evidence Generation in Oncology.
Khozin S; Blumenthal GM; Pazdur R
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059439
[TBL] [Abstract][Full Text] [Related]
5. Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design.
Dagenais S; Russo L; Madsen A; Webster J; Becnel L
Clin Pharmacol Ther; 2022 Jan; 111(1):77-89. PubMed ID: 34839524
[TBL] [Abstract][Full Text] [Related]
6. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
Wu J; Wang C; Toh S; Pisa FE; Bauer L
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
[TBL] [Abstract][Full Text] [Related]
7. Trial designs using real-world data: The changing landscape of the regulatory approval process.
Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
[TBL] [Abstract][Full Text] [Related]
8. Generating real-world evidence from unstructured clinical notes to examine clinical utility of genetic tests: use case in BRCAness.
Zhao Y; Weroha SJ; Goode EL; Liu H; Wang C
BMC Med Inform Decis Mak; 2021 Jan; 21(1):3. PubMed ID: 33407429
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two assessments of real-world data and real-world evidence for regulatory decision-making.
Yuan L; Rahman M; Concato J
Clin Transl Sci; 2024 Jan; 17(1):e13702. PubMed ID: 38093484
[TBL] [Abstract][Full Text] [Related]
10. Big data and real-world data-based medicine in the management of hypertension.
Okada M
Hypertens Res; 2021 Feb; 44(2):147-153. PubMed ID: 33250517
[TBL] [Abstract][Full Text] [Related]
11. Use of Real-world Data for New Drug Applications and Line Extensions.
Bolislis WR; Fay M; Kühler TC
Clin Ther; 2020 May; 42(5):926-938. PubMed ID: 32340916
[TBL] [Abstract][Full Text] [Related]
12. Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective.
Zhu R; Vora B; Menon S; Younis I; Dwivedi G; Meng Z; Datta-Mannan A; Manchandani P; Nayak S; Tammara BK; Garhyan P; Iqbal S; Dagenais S; Chanu P; Mukherjee A; Ghobadi C;
Clin Pharmacol Ther; 2023 Oct; 114(4):751-767. PubMed ID: 37393555
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?
van Nassau SCMW; Bol GM; van der Baan FH; Roodhart JML; Vink GR; Punt CJA; May AM; Koopman M; Derksen JWG
Curr Treat Options Oncol; 2024 Apr; 25(4):405-426. PubMed ID: 38367182
[TBL] [Abstract][Full Text] [Related]
14. Current status of real-world big data research in the cardiovascular field in Japan.
Tonegawa-Kuji R; Kanaoka K; Iwanaga Y
J Cardiol; 2023 Mar; 81(3):307-315. PubMed ID: 36126909
[TBL] [Abstract][Full Text] [Related]
15. Generating and using real-world data: A worthwhile uphill battle.
Verkerk K; Voest EE
Cell; 2024 Mar; 187(7):1636-1650. PubMed ID: 38552611
[TBL] [Abstract][Full Text] [Related]
16. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
[TBL] [Abstract][Full Text] [Related]
17. Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea.
Lee H; Ahn HS; Kwon S; Kang HY; Han E
Clin Transl Sci; 2024 Apr; 17(4):e13801. PubMed ID: 38629484
[TBL] [Abstract][Full Text] [Related]
18. Using real-world evidence in haematology.
Passamonti F; Corrao G; Castellani G; Mora B; Maggioni G; Della Porta MG; Gale RP
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101536. PubMed ID: 38490764
[TBL] [Abstract][Full Text] [Related]
19. Digital Health and Big Data Analytics: Implications of Real-World Evidence for Clinicians and Policymakers.
Magalhães T; Dinis-Oliveira RJ; Taveira-Gomes T
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886214
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Databases in Real-world Studies Regarding the Diverse Health Care Systems of India, Thailand, and Taiwan: Protocol for a Scoping Review.
Shau WY; Setia S; Shinde SP; Santoso H; Furtner D
JMIR Res Protoc; 2022 Dec; 11(12):e43741. PubMed ID: 36512386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
